scholarly journals Two Cases of Idiopathic Mesenteric Phlebosclerosis Possibly Associated with Long-term Use of a Chinese Herbal Medicine

2014 ◽  
Vol 75 (5) ◽  
pp. 1202-1207 ◽  
Author(s):  
Uki OOKI ◽  
Kazuhiro SUGITANI ◽  
Yutaka YOSHIDA ◽  
Tooru TAKAHASHI
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Chinese Herbal

scholarly journals Acupuncture plus Chinese Herbal Medicine for Irritable Bowel Syndrome with Diarrhea: A Systematic Review and Meta-Analysis

2019 ◽  
Vol 2019 ◽  
pp. 1-16 ◽  
Author(s):  
Jing Yan ◽  
Zhi-wei Miao ◽  
Jun Lu ◽  
Fei Ge ◽  
Li-hua Yu ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Western Medicine ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Combined Method ◽  
Chinese Herbal ◽  
Irritable Bowel

Purpose. To comprehensively evaluate the efficacy and safety of acupuncture combined with Chinese herbal medicine (CHM) in treating irritable bowel syndrome with diarrhea (IBS-D). Methods. Relevant randomized controlled trials (RCTs) were systemically retrieved from electronic databases from inception to March 2018, including the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Biological Medical Database (CBM, SinoMed), China Science and Technology Journal Database (VIP), and Wan Fang Data. Meanwhile, pooled estimates, including the 95% confidence interval (CI), were calculated for primary and secondary outcomes of IBS-D patients. Besides, quality of relevant articles was evaluated using the Cochrane Collaboration’s risk of bias tool, and the Review Manager 5.3 and Stata12.0 softwares were employed for analyses. Results. A total of 21 RCTs related to IBS-D were included into this meta-analysis. Specifically, the pooled results indicated that (1) acupuncture combined with CHM might result in more favorable improvements compared with the control group (relative risk [RR] 1.29; 95% CI 1.24–1.35; P =0.03); (2) the combined method could markedly enhance the clinical efficacy in the meantime of remarkably reducing the scores of abdominal pain (standardized mean difference [SMD] –0.45; 95% CI –0.72, –0.17; P = 0.002), abdominal distention/discomfort (SMD –0.36; 95% CI –0.71, –0.01; P = 0.04), diarrhea (SMD –0.97; 95% CI –1.18, –0.75; P < 0.00001), diet condition (SMD –0.73; 95% CI –0.93, –0.52; P<0.00001), physical strength (SMD –1.25; 95% CI –2.32, –0.19; P = 0.02), and sleep quality (SMD –1.02; 95% CI –1.26, –0.77; P < 0.00001) compared with those in the matched groups treated with western medicine, or western medicine combined with CHM. Additionally, a metaregression analysis was constructed according to the name of prescription, acupuncture type, treatment course and publication year, and subgroup analyses stratified based on the names of prescriptions and acupoints location were also carried out, so as to explore the potential heterogeneities; and (3) IBS-D patients treated with the combined method only developed inconspicuous adverse events; more importantly, the combined treatment had displayed promising long-term efficacy. Conclusions. Findings in this study indicate that acupuncture combined with CHM is suggestive of an effective and safe treatment approach for IBS-D patients, which may serve as a promising method to treat IBS-D in practical application. However, more large-scale, multicenter, long-term, and high-quality RCTs are required in the future, given the small size, low quality, and high risk of the studies identified in this meta-analysis.

scholarly journals Idiopathic mesenteric phlebosclerosis associated with long-term use of Chinese herbal medicine

2018 ◽  
Vol 29 (1) ◽  
pp. 138-140 ◽  
Author(s):  
Hsing Jung Yeh ◽  
Pao Ying Lin ◽  
Wei-Yu Kao ◽  
Ching Huei Kun ◽  
Chun Chao Chang
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Chinese Herbal

scholarly journals Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study

2021 ◽  
Vol 12 ◽  
Author(s):  
Jenny Chun-Ling Guo ◽  
Heng-Chih Pan ◽  
Bo-Yan Yeh ◽  
Yen Chu Lu ◽  
Jiun-Liang Chen ◽  
...  
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Lower Risk ◽  
Population Based ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chinese Herbal ◽  
Risk Of Mortality ◽  
All Cause Mortality

Background: Chronic kidney disease (CKD) has become a worldwide burden due to the high co-morbidity and mortality. Diabetic nephropathy (DN) is one of the leading causes of CKD, and pre-dialysis is one of the most critical stages before the end-stage renal disease (ESRD). Although Chinese herbal medicine (CHM) use is not uncommon, the feasibility of using CHM among pre-dialysis DN patients remains unclear.Materials and methods: We analyzed a population-based cohort, retrieved from Taiwan’s National Health Insurance Research Database, to study the long-term outcome of using CHM among incident pre-dialysis DN patients from January 1, 2004, to December 31, 2007. All patients were followed up to 5 years or the occurrence of mortality. The risks of all-cause mortality and ESRD were carried out using Kaplan-Meier and competing risk estimation, respectively. Further, we demonstrated the CHM prescriptions and core CHMs using the Chinese herbal medicine network (CMN) analysis.Results: A total of 6,648 incident pre-dialysis DN patients were analyzed, including 877 CHM users and 5,771 CHM nonusers. With overlap weighing for balancing all accessible covariates between CHM users and nonusers, we found the use of CHM was associated with lower all-cause mortality (0.22 versus 0.56; log-rank test: p-value &lt;0.001), and the risk of mortality was 0.42 (95% CI: 0.36–0.49; p-value &lt;0.001) by adjusting all accessible covariates. Further, the use of CHM was associated with a lower risk of ESRD (cause-specific hazard ratio: 0.59, 95%CI: 0.55–0.63; p-value &lt;0.001). Also, from the 5,901 CHM prescriptions, we found Ji-Sheng-Shen-Qi-Wan, Astragalus mongholicus Bunge or (Astragalus membranaceus (Fisch.) Bge.), Plantago asiatica L. (or Plantago depressa Willd.), Salvia miltiorrhiza Bunge, and Rheum palmatum L. (or Rheum tanguticum (Maxim. ex Regel) Balf., Rheum officinale Baill.) were used as core CHMs for different CHM indications. Use of core CHMs was associated with a lower risk of mortality than CHM users without using core CHMs.Conclusions: The use of CHM seemed feasible among pre-dialysis DN patients; however, the beneficial effects still need to be validated by well-designed clinical trials.

scholarly journals The long-term consequences of Corona Virus Disease 2019 patients receiving Chinese herbal medicine treatments in acute phase

Medicine ◽  
2021 ◽  
Vol 100 (29) ◽  
pp. e26677
Author(s):  
Yi-ming Sun ◽  
Jia-yan Liu ◽  
Ran Sun ◽  
Jie Zhang ◽  
Meng-lu Xiao ◽  
...  
Keyword(s):  
Herbal Medicine ◽  
Acute Phase ◽  
Chinese Herbal Medicine ◽  
Virus Disease ◽  
Chinese Herbal ◽  
Corona Virus ◽  
Long Term Consequences

scholarly journals Clinical observation on chinese herbal medicine in treatment of long-term insomnia

2000 ◽  
Vol 6 (2) ◽  
Author(s):  
David Wang ◽  
Charlie Xue ◽  
Noel Lim ◽  
Woei-Jia Jiang ◽  
Jennifer R Jamison
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Clinical Observation ◽  
Chinese Herbal

Eight-Year Survival of AIDS Patients Treated with Chinese Herbal Medicine

2014 ◽  
Vol 42 (02) ◽  
pp. 261-274 ◽  
Author(s):  
Hai-Lu Zhao ◽  
Chuan-Zheng Sun ◽  
Wei-Ping Jiang ◽  
Zhi-Kai Dai ◽  
Wu-Xiang Shi ◽  
...  
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Survival Probability ◽  
T Test ◽  
Aids Patients ◽  
Term Survival ◽  
Long Term Survival ◽  
Chinese Herbal ◽  
Paired T Test

Treatment of acquired immunodeficiency syndrome (AIDS) currently relies on the use of antiretroviral drugs. Little is known about Chinese herbal medicine (CHM) outcomes in patients living with AIDS. We conducted a cohort study to investigate long-term survival among CHM-treated AIDS patients. Patients were poor farmers who contracted HIV-1 infection when selling blood in the 1990s. Symptoms of AIDS included recurring respiratory tract infections with a clinical diagnosis of pneumonia, swollen lymph nodes and weight loss. 385 patients with AIDS were included and 165 of them used a 16-herb formula for 14 days to 9 months. The eight-year survival rate was 87% for the CHM users and 34% for the non-users (increased survival probability for CHM user, 9.6; 95% CI = 6.0–15.4; p < 0.0001). Survival probability further increased 14.6-fold (95% CI = 8.2–26.1), when excluding the users who received CHM for less than three months. Zero deaths were found in patients who used CHM for six to nine months. All the survivors regained their body weight and none of them experienced a relapse of AIDS or any severe adverse events. After the CHM treatment for an average of 3.6 months, the plasma HIV load was 74.7% lower (paired t-test, p = 0.151) and the number of blood CD4+ lymphocytes increased from 253 to 314 (paired t-test, p = 0.021). Without life-long medication, CHM may be beneficial for long-term survival of AIDS patients.

Long-term use of combined conventional medicine and Chinese herbal medicine decreases the mortality risk of patients with lung cancer

2020 ◽  
Vol 52 ◽  
pp. 102427
Author(s):  
Ming-Hsien Yeh ◽  
Hsien-Chang Wu ◽  
Nai-Wei Lin ◽  
Jin-Jian Hsieh ◽  
Jin-Wen Yeh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Mortality Risk ◽  
Conventional Medicine ◽  
Chinese Herbal
Sign in / Sign up

Export Citation Format

Share Document